NOTE 13. – INCOME TAXES

Pre-tax earnings from continuing operations consisted of the following for the years ended December 31:

  ​ ​ ​

2025

  ​ ​ ​

2024

Pre-tax income (loss)

 

  ​

 

  ​

U.S.

$

(13,145)

$

(15,465)

Outside the U.S.

 

 

Total pre-tax (loss) earnings

$

(13,145)

$

(15,465)

The following is a summary of the components giving rise to the (benefit) provision for income taxes from continuing operations for the years ended December 31:

  ​ ​ ​

2025

  ​ ​ ​

2024

Federal provision:

 

  ​

 

  ​

Current provision

$

$

Deferred provision

 

(2,650)

 

(3,355)

Change in valuation allowance

 

2,657

 

3,363

Total federal income tax provision

7

8

State provision:

 

  ​

 

  ​

Current provision

(35)

 

22

Deferred provision

 

(325)

 

97

Change in valuation allowance

 

325

 

(97)

Total state income tax (benefit) provision

(35)

22

Foreign provision:

 

  ​

 

  ​

Current provision

 

Deferred provision

 

 

Change in valuation allowance

 

 

Total foreign income tax (benefit) provision

Total income tax (benefit) provision

$

(28)

$

30

The provision for income tax from continuing operations varies from that which would be expected based on applying the statutory federal rate to pre-tax book loss, including the effect of the change in the U.S. corporate income tax rates, as follows:

  ​ ​ ​

2025

2024

U.S. federal statutory tax rate

 

$

(2,760)

21.0

%  

$

(3,248)

21.0

%  

State and local income taxes, net of federal income tax effect (a)

 

(28)

0.2

 

17

(0.1)

 

Foreign Tax Effects

Canada

Effect of changes in tax laws or rates enacted in current period

Effect of cross-border tax laws

Tax credits

Research and development credit carryforward

 

 

(230)

1.5

 

Changes in valuation allowances

2,657

(20.2)

3,363

(21.7)

Nontaxable or nondeductible items

Stock based compensation (b)

 

12

(0.1)

 

812

(5.3)

 

GVB sale adjustments

(615)

4.0

Other

105

(0.8)

(80)

0.5

Changes in unrecognized tax benefits

Other adjustments

(14)

0.1

11

(0.1)

Effective tax rate (benefit) provision

 

$

(28)

0.2

%  

$

30

(0.2)

%  

(a) State benefits in Texas made up the majority (greater than 50 percent) of the tax effect in this category.

(b) In 2025, incentive stock options not deductible. In 2024, forfeitures of $563, cancellations of $45, and shortfalls of $204.

Individual components of deferred taxes consist of the following as of December 31:

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred tax assets:

 

  ​

 

  ​

Net operating loss carryforward

$

62,743

$

59,605

Inventory

 

615

 

990

Stock-based compensation

 

89

 

Start-up expenditures

 

102

 

124

Research and development credit carryforward

 

1,654

 

1,654

Severance liability

 

 

24

Allowance for credit losses

102

2

Research and development costs

327

1,827

Operating lease obligations

 

187

 

400

Capital loss on investment

2,716

2,622

Interest expense limitation

2,775

2,259

Note payable and warrant liability

373

Other

 

141

 

314

$

71,451

$

70,194

Deferred tax liabilities:

 

  ​

 

  ​

Machinery and equipment

 

(334)

 

(334)

Patents and trademarks

 

(124)

 

(149)

Operating lease right-of-use assets

 

(177)

 

(386)

Other intangible assets

 

(461)

 

(409)

 

(1,096)

 

(1,278)

Valuation allowance

 

(70,435)

 

(68,989)

Net deferred taxes

$

(80)

$

(73)

The Company has US federal net operating loss (“NOL”) carryforwards of approximately $228,923 as of December 31, 2025 that do not expire. The Company also accumulated US federal NOL carryforward of approximately $46,920 through December 31, 2017 and these NOL carryforwards begins to expire in 2030. In addition to the US federal NOL carryforward, the Company has state NOL carryforwards of approximately $104,844 in various jurisdictions in which it files that will begin to expire in 2031. As of December 31, 2025, the Company has a research and development credit carryforward of approximately $1,654 that begins to expire in 2030. The Company has a capital loss carryover of approximately $11,188 as of December 31, 2025, that begins to expire in 2026. Utilization of these carryforwards may be subject to an annual limitation in the case of equity ownership changes, as defined by law. Due to the uncertainty of the Company’s ability to generate sufficient taxable income in the future, the Company has recorded a valuation allowance to reduce the net deferred tax asset associated with the definite lived assets to zero. These carryforwards are included in the net deferred tax asset that has been fully offset by the valuation allowance. The valuation allowance increased for continuing operations by $2,982 and $3,305 for the years ended December 31, 2025 and 2024, respectively, and changed by ($1,537) and $922 due to tax attributes that were generated as a part of discontinued operations but remain on a prospective basis with continuing operations due to the Company filing a consolidated U.S. federal return for the years ended December 31, 2025 and 2024.

ASC 740 provides guidance on the financial statement recognition and measurement for uncertain income tax positions that are taken or expected to be taken in a company’s income tax return. The Company has evaluated its tax positions and believes there are no uncertain tax positions as of December 31, 2025 and 2024.

The following tax payments and received refunds during the years ended December 31, 2025 and 2024, were as follows:

  ​ ​ ​

2025

  ​ ​ ​

2024

U.S. federal

 

$

 

$

State

Texas

(32)

7

Georgia

 

(7)

 

7

Oregon

 

2

 

(2)

New York

10

California

3

North Carolina

(4)

Other

 

2

 

1

State Subtotal

$

(35)

$

22

Foreign

 

  ​

 

  ​

Other

 

 

Total cash paid or income taxes (net of refunds)

$

(35)

$

22

The One Big Beautiful Bill Act ("OBBB") was signed into law on July 4, 2025. The OBBB makes changes to the U.S. corporate income tax, including immediate expensing of domestic research and development costs, with retroactive application beginning January 1, 2025; reinstating the option to claim 100% accelerated depreciation deductions on qualified property, with retroactive application beginning January 20, 2025; permanent reinstatement of the EBITDA-based limitation for the business interest deduction under IRC Section 163(j); and international tax provisions modifying global intangible low-taxed income ("GILTI"), foreign-derived intangible income ("FDII"), and base erosion and anti-abuse tax ("BEAT"). The impact of the OBBB on the Company is accelerating the expensing of the domestic research and development costs.

Historical Timeline

Fiscal YearFiled
2025Mar 26, 2026Showing above
2024Mar 20, 2025
2023Mar 28, 2024
2022Mar 9, 2023
2021Mar 1, 2022

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.